Gatifloxacin activity against quinolone-resistant gyrase: Allele- specific enhancement of bacteriostatic and bactericidal activities by the C- 8-methoxy group

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2969-2974

  Lu, Tao ^a   Zhao, Xilin ^a   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; GYRASE INHIBITOR;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM MUTANT; DRUG EFFECT; DRUG SCREENING; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL;

EID: 0032785619     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2969     Document Type: Article

References (25)

1. Chen, C.-R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637.
2. Dong, Y., C. Xu, X. Zhao, J. Domagala, and K. Drlica. 1998. Fluoroquinolone action against mycobacteria: effects of C8 substituents on bacterial growth, survival, and resistance. Antimicrob. Agents Chemother. 42:2978-2984.
3. Dong, Y., X. Zhao, J. Domagala, and K. Drlica. 1999. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1756-1758.
4. Drlica, K. 1999. Mechanism of fluoroquinolone action. Curr. Opin. Microbiol. 2:504-508.
5. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
6. Friedman, S. M., M. Malik, and K. Drlica. 1995. DNA supercoiling in a thermotolerant mutant of Escherichia coli. Mol. Gen. Genet. 248:417-422.
7. Ito, T., M. Matsumoto, and T. Nishino. 1995. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci. Antimicrob. Agents Chemother. 39:1522-1525.
8. Kampranis, S., and A. Maxwell. 1998. Conformational changes in DNA gyrase revealed by limited proteolysis. J. Biol. Chem. 273:22606-22614.
9. Kampranis, S., and A. Maxwell. 1998. The DNA gyrase-quinolone complex, ATP hydrolysis and the mechanism of DNA cleavage. J. Biol. Chem. 273: 22615-22626.
10. Karabalut, N., and G. L. Drusano. 1993. Pharmacokinetics of the quinolone antimicrobial agents, p. 195-223. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents. American Society for Microbiology, Washington, D.C.
11. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
12. Kitamura, A., K. Hoshino, Y. Kimura, I. Hayakawa, and K. Sato. 1995. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1467-1471.
13. Miller, J. 1972. Experiments in molecular genetics, p. 466. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
14. Morais-Cabral, J. H., A. P. Jackson, C. V. Smith, N. Shikotra, A. Maxwell, and R. C. Liddington. 1997. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388:903-906.
15. Nakamura, S. 1997. Mechanisms of quinolone resistance. J. Infect. Chemother. 3:128-138.
16. Ng, E. Y., M. Trucksis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
17. Pruss, G., R. Franco, S. Chevalier, S. Manes, and K. Drlica. 1986. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol. 168:276-282.
18. Schedletzky, H., B. Wiedemann, and P. Heisig. 1999. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus. J. Antimicrob. Chemother. 43(Suppl. B):31-37.
19. Smith, J. 1986. The mode of action of 4-quinolones and possible mechanisms of resistance. J. Antimicrob. Chemother. 18(Suppl. D):21-29.
20. Sternglanz, R., S. DiNardo, K. A. Voelkel, Y. Nishimura, Y. Hirota, A. K. Becherer, L. Zumstein, and J. C. Wang. 1981. Mutations in the gene coding for Escherichia coli DNA topoisomerase I affecting transcription and transposition. Proc. Natl. Acad. Sci. USA 78:2747-2751.
21. Takei, M., H. Fukuda, T. Yasue, M. Hosaka, and Y. Oomori. 1998. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases. Antimicrob. Agents Chemother. 42:2678-2681.
22. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
23. Zhao, B.-Y., R. Pine, J. Domagala, and K. Drlica. 1999. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C8-methoxyl group on survival in liquid media and in human macrophages. Antimicrob. Agents Chemother. 43:661-666.
24. Zhao, X., J.-Y. Wang, C. Xu, Y. Dong, J. Zhou, J. Domagala, and K. Drlica. 1998. Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones. Antimicrob. Agents Chemother. 42:956-958.
25. Zhao, X., C. Xu, J. Domagala, and K. Drlica. 1997. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc. Natl. Acad. Sci. USA 94:13991-13996.